STING1 and hepatocellular carcinoma: The activation of the cGAS-STING pathway has received attention for its prognostic value in gastric cancer and hepatocellular carcinoma (Qi et al., 2020; Yang et al., 2021), it is unknown whether cGAS-STING may also be potential prognostic value in BRCA.